Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent. [electronic resource]
Producer: 20160614Description: 324-330 p. digitalISSN:- 1090-2104
- Animals
- Apoptosis -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Evaluation, Preclinical -- methods
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Mice
- Mice, SCID
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.